Recombinant fibroblast interferon and immune interferon for treating chronic hepatitis B virus infection: patients' tolerance and the effect on viral markers

J Infect Dis. 1988 May;157(5):1076-80. doi: 10.1093/infdis/157.5.1076.
No abstract available

Publication types

  • Clinical Trial
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Chronic Disease
  • DNA-Directed DNA Polymerase / blood*
  • Drug Therapy, Combination
  • Hepatitis B / microbiology
  • Hepatitis B / therapy*
  • Hepatitis B virus / enzymology*
  • Hepatitis, Chronic / therapy
  • Homosexuality
  • Humans
  • Interferon Type I / administration & dosage
  • Interferon Type I / adverse effects
  • Interferon Type I / therapeutic use*
  • Interferon-gamma / administration & dosage
  • Interferon-gamma / adverse effects
  • Interferon-gamma / therapeutic use*
  • Male
  • Recombinant Proteins

Substances

  • Interferon Type I
  • Recombinant Proteins
  • Interferon-gamma
  • DNA-Directed DNA Polymerase